Following these transactions, Schneider's direct ownership in Ionis Pharmaceuticals (NASDAQ:IONS) stands at 58,508 shares.

If everything that occurs at the microscopic, molecular level in plants and animals and other life forms occurs as a result ...

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.

Discover the challenges and treatments for Werner Syndrome, a rare genetic condition causing early aging and skin ulcers.

Could a new organ reshape who you are? The mysterious link between organ transplants, cellular memory, and identity.

The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential ...

Scientists at the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have discovered a ...